{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:10:52Z","timestamp":1784268652685,"version":"3.55.0"},"reference-count":102,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Aspiration pneumonia (AP), a serious condition resulting from the inhalation of foreign materials into the lungs, is a significant concern for patients with compromised swallowing mechanisms, especially those with neurological disorders. Sialorrhea (hypersalivation) exacerbates the risk of aspiration, and botulinum neurotoxin type A (BoNT-A) has been identified as a potential treatment to manage sialorrhea. However, the direct impact of BoNT-A on reducing AP risk remains inadequately explored, particularly in adult populations. BoNT-A works by inhibiting the release of acetylcholine at the neuromuscular junction, thereby reducing salivary gland stimulation and saliva production.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This review aims to evaluate the current state of research on the use of BoNT-A for managing sialorrhea and its potential to reduce AP risk, with a specific focus on the adult population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive review of existing literature was conducted, focusing on the efficacy of BoNT-A in treating sialorrhea in both pediatric and adult populations. Studies were assessed for their findings on the impact of BoNT-A on drooling and related complications, including the risk of AP. Meta-analyses and individual studies were reviewed to summarize the current knowledge and identify research gaps.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In pediatric patients, BoNT-A has been shown to effectively reduce sialorrhea, with several studies and meta-analyses demonstrating its efficacy in managing drooling associated with neurological conditions such as cerebral palsy. However, evidence linking BoNT-A directly to reduced AP risk is limited. In adults, while BoNT-A has been beneficial in managing sialorrhea associated with conditions such as Parkinson's disease and brain injuries, studies specifically exploring its impact on AP risk are lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Current evidence supports the efficacy of BoNT-A in managing neurological sialorrhea across both adult and pediatric populations. However, a critical gap exists in studies directly investigation whether BoNT-A reduces AP risk in adults with neurological disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1851936","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:45:13Z","timestamp":1784267113000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Botulinum toxin A for sialorrhea in adults with neurological disorders: a narrative review of aspiration pneumonia risk"],"prefix":"10.3389","volume":"17","author":[{"given":"Sultan","family":"Alzarouni","sequence":"first","affiliation":[{"name":"Parkinson's Foundation Center of Excellence, King's College Hospital, King's College London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishab","family":"Sati","sequence":"additional","affiliation":[{"name":"School of Medicine, The Royal College of Surgeons in Ireland (RCSI)","place":["Dublin, Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashanth","family":"Reddy","sequence":"additional","affiliation":[{"name":"Parkinson's Foundation Center of Excellence, King's College Hospital, King's College London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubasher A.","family":"Qamar","sequence":"additional","affiliation":[{"name":"Parkinson's Foundation Center of Excellence, King's College Hospital, King's College London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/practneurol-2016-001515","article-title":"Management of oral secretions in neurological disease","volume":"17","author":"McGeachan","year":"2017","journal-title":"Pract Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/mdc3.70077","article-title":"Self-perception of drooling impact in people with parkinson's disease: a case-control and cross-sectional study","volume":"12","author":"Nascimento","year":"2025","journal-title":"Mov Disord Clin Pract."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1756286419888601","DOI":"10.1177\/1756286419888601","article-title":"The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin\u00ae)","volume":"12","author":"Morgante","year":"2019","journal-title":"Ther Adv Neurol Disord."},{"key":"B4","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3390\/toxins16080366","article-title":"Real-world observational analysis of clinical characteristics and treatment patterns of patients with chronic sialorrhea","volume":"16","author":"Hast","year":"2024","journal-title":"Toxins."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1007\/s10072-020-04495-2","article-title":"Dysphagia in neurological diseases: a literature review","volume":"41","author":"Panebianco","year":"2020","journal-title":"Neurol Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.ccm.2018.01.007","article-title":"Swallowing and secretion management in neuromuscular disease","volume":"39","author":"Britton","year":"2018","journal-title":"Clin Chest Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e3164","DOI":"10.1002\/brb3.3164","article-title":"Botulinum toxin in the treatment of sialorrhea in severe neurological patients with tracheotomy","volume":"13","author":"Shao","year":"2023","journal-title":"Brain Behav."},{"key":"B8","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1542\/peds.2003-1104-L","article-title":"Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial","volume":"114","author":"Jongerius","year":"2004","journal-title":"Pediatrics."},{"key":"B9","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.mpsur.2012.09.010","article-title":"Physiology of the salivary glands","volume":"30","author":"Varga","year":"2012","journal-title":"Surgery."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.3390\/toxins5051010","article-title":"Sialorrhea: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins","volume":"5","author":"Lakraj","year":"2013","journal-title":"Toxins."},{"key":"B11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/prd.12116","article-title":"The physiology of salivary secretion","volume":"70","author":"Proctor","year":"2016","journal-title":"Periodontology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2147\/JPRLS.S177409","article-title":"Sialorrhea in Parkinson's disease: prevalence, impact and management strategies","volume":"9","author":"Miller","year":"2019","journal-title":"Res Rev Parkinsonism."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1080\/14737175.2021.1979959","article-title":"Critical review of incobotulinum toxinA in the treatment of chronic sialorrhea in pediatric patients","volume":"21","author":"Jost","year":"2021","journal-title":"Expert Rev Neurother."},{"key":"B14","doi-asserted-by":"publisher","first-page":"104433","DOI":"10.1016\/j.amjoto.2024.104433","article-title":"Navigating the spectrum of pediatric sialorrhea management: a narrative review","volume":"45","author":"Kronlage","year":"2024","journal-title":"Am J Otolaryngol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"100223","DOI":"10.1016\/j.prdoa.2023.100223","article-title":"Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson's disease","volume":"9","author":"Bergmans","year":"2023","journal-title":"Clin Park Relat Disord."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17549507.2025.2544784","article-title":"The impact of drooling on the lives of people with Parkinson's disease","volume":"27","author":"Cocks","year":"2025","journal-title":"Int J Speech Lang Pathol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/08919887231195219","article-title":"Caregiver burden in parkinson disease: a scoping review of the literature from 2017-2022","volume":"37","author":"Aamodt","year":"2023","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00455-015-9671-9","article-title":"Dysphagia in Parkinson's disease","volume":"31","author":"Suttrup","year":"2016","journal-title":"Dysphagia."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1111\/nmo.12690","article-title":"High prevalence of colonization of oral cavity by respiratory pathogens in frail older patients with oropharyngeal dysphagia","volume":"27","author":"Ortega","year":"2015","journal-title":"Neurogastroenterol Motil."},{"key":"B20","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/ageing\/aft164","article-title":"Oral health in older patients with oropharyngeal dysphagia","volume":"43","author":"Ortega","year":"2014","journal-title":"Age Ageing."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.17245\/jdapm.2017.17.1.1","article-title":"Pneumonitis and pneumonia after aspiration","volume":"17","author":"Son","year":"2017","journal-title":"J Dent Anesth Pain Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"S567","DOI":"10.33549\/\/physiolres.934767","article-title":"Aspiration syndromes and associated lung injury: incidence, pathophysiology and management","volume":"70","author":"Ko\u0161utova","year":"2021","journal-title":"Physiol Res"},{"key":"B23","article-title":"Aspiration pneumonia","author":"Sanivarapu","year":"2026","journal-title":"StatPearls"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e16449","DOI":"10.1111\/ene.16449","article-title":"Risk of aspiration pneumonia and hospital mortality in Parkinson disease: a systematic review and meta-analysis","volume":"5","author":"Chua","year":"2024","journal-title":"Eur J Neurol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/17482960601147461","article-title":"Incidence of aspiration pneumonia in ALS in Olmsted County, MN","volume":"8","author":"Sorenson","year":"2007","journal-title":"Amyotroph Lateral Scler."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0135823","DOI":"10.1371\/journal.pone.0135823","article-title":"Impact of aspiration pneumonia on the clinical course of progressive supranuclear palsy: a retrospective cohort study","volume":"10","author":"Tomita","year":"2015","journal-title":"PLoS ONE."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e820","DOI":"10.1212\/WNL.0000000000008907","article-title":"Multiple cause of death analysis in multiple sclerosis: a population-based study","volume":"94","author":"Harding","year":"2020","journal-title":"Neurology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4102\/sajcd.v63i1.102","article-title":"Implementing oral care to reduce aspiration pneumonia amongst patients with dysphagia in a South African setting","volume":"63","author":"Seedat","year":"2016","journal-title":"S Afr J Commun Disord."},{"key":"B29","doi-asserted-by":"publisher","first-page":"CD008624","DOI":"10.1002\/14651858.CD008624.pub2","article-title":"Interventions for drooling in children with cerebral palsy","volume":"11","author":"Walshe","year":"2012","journal-title":"Cochrane Database Syst Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s00455-022-10408-6","article-title":"Expiratory muscle strength training for drooling in adults with Parkinson's disease","volume":"37","author":"Cocks","year":"2022","journal-title":"Dysphagia."},{"key":"B31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2169\/internalmedicine.2373-18","article-title":"Management of dysphagia in patients with Parkinson's disease and related disorders","volume":"59","author":"Umemoto","year":"2020","journal-title":"Intern Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1093\/pch\/pxab051","article-title":"Anticholinergic treatment for sialorrhea in children: a systematic review","volume":"27","author":"You","year":"2021","journal-title":"Paediatr Child Health."},{"key":"B33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.parkreldis.2016.07.001","article-title":"Drooling in Parkinson's disease: a randomized controlled trial of incobotulinum toxin A and meta-analysis of Botulinum toxins","volume":"30","author":"Narayanaswami","year":"2016","journal-title":"Parkinsonism Relat Disord."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1212\/WNL.0b013e3181d8c1b7","article-title":"Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial","volume":"74","author":"Arbouw","year":"2010","journal-title":"Neurology."},{"key":"B35","first-page":"287","article-title":"Treating sialorrhea in neurological disorders: a state-of-the-art review","volume":"27","author":"Mistry","year":"2012","journal-title":"Dysphagia."},{"key":"B36","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3390\/toxins14090585","article-title":"Safety profile and lack of immunogenicity of incobotulinumtoxina in pediatric spasticity and sialorrhea: a pooled analysis","volume":"14","author":"Berweck","year":"2022","journal-title":"Toxins."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/dmcn.14888","article-title":"Posterior drooling in children with cerebral palsy and other neurodevelopmental disorders","volume":"63","author":"Delsing","year":"2021","journal-title":"Dev Med Child Neurol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/ene.15083","article-title":"Efficacy and safety of botulinum toxin for treating sialorrhea: A systematic review and meta-analysis","volume":"29","author":"Yu","year":"2022","journal-title":"Eur J Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ijporl.2019.05.044","article-title":"Effects of salivary gland botulinum Toxin-A on drooling and respiratory morbidity in children with neurological dysfunction","volume":"124","author":"Gubbay","year":"2019","journal-title":"Int J Pediatr Otorhinolaryngol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40360-023-00694-7","article-title":"The effectiveness and safety of botulinum toxin injections for the treatment of sialorrhea with Parkinson's disease: a systematic review and meta-analysis","volume":"24","author":"Yang","year":"2023","journal-title":"BMC Pharmacol Toxicol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"796","DOI":"10.5535\/arm.2013.37.6.796","article-title":"Botulinum toxin in the treatment of drooling in tetraplegic patients with brain injury","volume":"37","author":"Ko","year":"2013","journal-title":"Ann Rehabil Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.clineuro.2003.10.012","article-title":"Ultrasound-guided versus \u2018blind' intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease","volume":"106","author":"Dogu","year":"2004","journal-title":"Clin Neurol Neurosurg."},{"key":"B43","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3233\/JPD-140379","article-title":"Sialorrhea in patients with Parkinson's disease: safety and administration of botulinum neurotoxin","volume":"4","author":"Egevad","year":"2014","journal-title":"J Parkinsons Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/mds.10420","article-title":"Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism","volume":"18","author":"Mancini","year":"2003","journal-title":"Mov Disord."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.3390\/toxins7093758","article-title":"Double-blind randomized controlled trial investigating the most efficacious dose of botulinum toxin-a for sialorrhea treatment in asian adults with neurological diseases","volume":"7","author":"Mazlan","year":"2015","journal-title":"Toxins."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1007\/s00784-023-04981-9","article-title":"Effectiveness of the pharmacological treatments for sialorrhea in patients with Parkinson's disease: a systematic review and network meta-analysis","volume":"27","author":"Santos Junior","year":"2023","journal-title":"Clin Oral Investig"},{"key":"B47","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1080\/02699052.2024.2444536","article-title":"The effectiveness and safety of botulinum toxin treatment for sialorrhea due to severe brain injury","volume":"39","author":"Clark","year":"2025","journal-title":"Brain Inj."},{"key":"B48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fneur.2023.1275807","article-title":"Botulinum neurotoxin type A in the interdisciplinary treatment of sialorrhea in adults and children\u2014update and practice recommendations","author":"Jost","year":"2023","journal-title":"Front Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1001\/jamaoto.2013.1328","article-title":"Long-term safety and efficacy data on botulinum toxin type A: an injection for sialorrhea","volume":"139","author":"Chan","year":"2013","journal-title":"JAMA Otolaryngol Head Neck Surg."},{"key":"B50","doi-asserted-by":"publisher","first-page":"6597","DOI":"10.1038\/s41598-021-86011-w","article-title":"Risk and mortality of aspiration pneumonia in Parkinson's disease: a nationwide database study","volume":"11","author":"Won","year":"2021","journal-title":"Sci Rep."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.parkreldis.2015.06.020","article-title":"Incidence and mortality trends of aspiration pneumonia in Parkinson's disease in the United States, 1979-2010","volume":"21","author":"Akbar","year":"2015","journal-title":"Parkinsonism Relat Disord."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.3233\/JPD-212798","article-title":"Clinical and economic outcomes associated with dysphagia in hospitalized patients with Parkinson's disease","volume":"11","author":"Di Luca","year":"2021","journal-title":"J Parkinsons Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.2147\/NDT.S99365","article-title":"Risk factors for pneumonia among patients with Parkinson's disease: a Taiwan nationwide population-based study","volume":"12","author":"Chang","year":"2016","journal-title":"Neuropsychiatr Dis Treat."},{"key":"B54","doi-asserted-by":"publisher","first-page":"P04","DOI":"10.1212\/WNL.80.7_supplement.P04.144","article-title":"Long-term analysis of aspiration pneumonia in patients with parkinson's disease (P04","volume":"80","author":"Akbar","year":"2013","journal-title":"Neurology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1136\/jnnp.2008.149708","article-title":"Cause of death and clinical grading criteria in a cohort of amyotrophic lateral sclerosis cases undergoing autopsy from the Scottish motor neurone disease register","volume":"80","author":"Kurian","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B56","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1212\/01.WNL.0000046586.38284.60","article-title":"The effect of pneumonia on mortality among patients hospitalized for acute stroke","volume":"60","author":"Katzan","year":"2003","journal-title":"Neurology."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e0213825","DOI":"10.1371\/journal.pone.0213825","article-title":"Pneumonia-associated death in patients with dementia: a systematic review and meta-analysis","volume":"14","author":"Manabe","year":"2019","journal-title":"PLoS ONE."},{"key":"B58","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.ejim.2012.08.006","article-title":"Aspiration pneumonia in old patients with dementia. Prognostic factors of mortality","volume":"23","author":"Bosch","year":"2012","journal-title":"Eur J Intern Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/mds.23929","article-title":"Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: a prospective double-blind trial","volume":"27","author":"Chinnapongse","year":"2012","journal-title":"Mov Disord."},{"key":"B60","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00415-009-0085-1","article-title":"Long-lasting benefits of botulinum toxin type B in Parkinson's disease-related drooling","volume":"256","author":"Lagalla","year":"2009","journal-title":"J Neurol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1212\/01.WNL.0000101713.81253.4C","article-title":"Double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease","volume":"62","author":"Ondo","year":"2004","journal-title":"Neurology."},{"key":"B62","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.clineuro.2008.12.007","article-title":"Does botulinum toxin injection in parotid glands interfere with the swallowing dynamics of Parkinson's disease patients?","volume":"111","author":"N\u00f3brega","year":"2009","journal-title":"Clin Neurol Neurosurg."},{"key":"B63","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/ane.12559","article-title":"Botulinum toxin-A injections vs radiotherapy for drooling in ALS","volume":"134","author":"Weikamp","year":"2016","journal-title":"Acta Neurol Scand."},{"key":"B64","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/mds.23473","article-title":"Botulinum toxin A versus B in sialorrhea: a prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease","volume":"26","author":"Guidubaldi","year":"2011","journal-title":"Mov Disord."},{"key":"B65","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/toxins10060217","article-title":"Incobotulinumtoxin A for Sialorrhea in neurological disorders: a real-life experience","volume":"10","author":"Mart\u00ednez-Poles","year":"2018","journal-title":"Toxins."},{"key":"B66","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1177\/000348940811700209","article-title":"Botulinum toxin injection to the salivary glands for the treatment of sialorrhea with chronic aspiration","volume":"117","author":"Raval","year":"2008","journal-title":"Ann Otol Rhinol Laryngol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00213-009-1689-y","article-title":"Botulinum toxin B as an effective and safe treatment for neuroleptic-induced sialorrhea","volume":"207","author":"Steinlechner","year":"2010","journal-title":"Psychopharmacology."},{"key":"B68","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1469-8749.2007.02015.x","article-title":"Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders","volume":"50","author":"Reid","year":"2008","journal-title":"Dev Med Child Neurol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"104119","DOI":"10.1016\/j.amjoto.2023.104119","article-title":"Comparing botulinum toxin and 4-duct ligation for Sialorrhea in children - a systematic review","volume":"45","author":"Ha","year":"2024","journal-title":"Am J Otolaryngol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"340","DOI":"10.5535\/arm.2012.36.3.340","article-title":"Effect of botulinum toxin a injection into the salivary glands for sialorrhea in children with neurologic disorders","volume":"36","author":"Jeung","year":"2012","journal-title":"Ann Rehabil Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jvir.2008.11.011","article-title":"Botulinum toxin A injection of salivary glands in children with drooling and chronic aspiration","volume":"20","author":"Pena","year":"2009","journal-title":"J Vasc Interv Radiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1002\/lary.31277","article-title":"Onabotulinum toxin A (BoNT-A) for drooling in children: a systematic review and meta-analysis","volume":"134","author":"Oad","year":"2024","journal-title":"Laryngoscope."},{"key":"B73","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ejpn.2016.04.010","article-title":"Management of drooling in children with cerebral palsy: a French survey","volume":"20","author":"Chal\u00e9at-Valayer","year":"2016","journal-title":"Eur J Paediatr Neurol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"e691","DOI":"10.1016\/j.bjoms.2021.10.010","article-title":"Effectiveness and safety of botulinum toxin in comparison with surgery for drooling in pediatric patients with neurological disorders: a systematic review","volume":"60","author":"Silva","year":"2022","journal-title":"Br J Oral Maxillofac Surg."},{"key":"B75","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s40120-019-00155-6","article-title":"Therapy of sialorrhea with botulinum neurotoxin","volume":"8","author":"Jost","year":"2019","journal-title":"Neurol Ther."},{"key":"B76","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/toxins10020055","article-title":"Botulinum toxin A for Sialorrhoea associated with neurological disorders: evaluation of the relationship between effect of treatment and the number of glands treated","volume":"10","author":"Restivo","year":"2018","journal-title":"Toxins."},{"key":"B77","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/01.mpg.0000175565.61072.1a","article-title":"The treatment of posterior drooling by botulinum toxin in a child with cerebral palsy","volume":"41","author":"Jongerius","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B78","doi-asserted-by":"publisher","first-page":"e1425","DOI":"10.1212\/WNL.0000000000012573","article-title":"Placebo-controlled clinical trial of incobotulinumtoxina for sialorrhea in children: SIPEXI","volume":"97","author":"Berweck","year":"2021","journal-title":"Neurology."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3390\/children8121089","article-title":"Botulinum toxin injections for treatment of drooling in children with cerebral palsy: a systematic review and meta-analysis","volume":"8","author":"Hung","year":"2021","journal-title":"Children."},{"key":"B80","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3109\/00016357.2010.545035","article-title":"Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms","volume":"69","author":"M\u00f8ller","year":"2011","journal-title":"Acta Odontol Scand."},{"key":"B81","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12883-015-0362-9","article-title":"Rate of aspiration pneumonia in hospitalized Parkinson's disease patients: a cross-sectional study","volume":"15","author":"Martinez-Ramirez","year":"2015","journal-title":"BMC Neurol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"875235","DOI":"10.3389\/fresc.2022.875235","article-title":"Comparative efficacy of botulinum toxin in salivary glands vs. oromotor therapy in the management of sialorrhea in cerebral palsy impact on sleep quality","volume":"3","author":"Marquez-Vazquez","year":"2022","journal-title":"Front Rehabil Sci."},{"key":"B83","first-page":"1195","article-title":"Botulinum toxin in the treatment of sialorrhea in neurological disorders","volume":"259","author":"Heckmann","year":"2012","journal-title":"J Neurol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jpainsymman.2008.02.006","article-title":"Systematic review of the effectiveness of botulinum toxin or radiotherapy for sialorrhea in patients with amyotrophic lateral sclerosis","volume":"37","author":"Stone","year":"2009","journal-title":"J Pain Symptom Manage."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.12912","article-title":"Salivary secretory disorders, inducing drugs, and clinical management","author":"Miranda-Rius","year":"2015","journal-title":"Int J Med Sci"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e1982","DOI":"10.1212\/WNL.0000000000007368","article-title":"Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea","volume":"92","author":"Jost","year":"2019","journal-title":"Neurology."},{"key":"B87","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/mus.21213","article-title":"Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients","volume":"39","author":"Jackson","year":"2009","journal-title":"Muscle Nerve"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1212\/wnl.61.9.1279","article-title":"A randomized trial of botulinum toxin A for treatment of drooling","volume":"61","author":"Lipp","year":"2003","journal-title":"Neurology"},{"key":"B89","article-title":"Predictors of mortality among nursing home residents with a diagnosis of Parkinson's disease","author":"Fernandez","year":"2002","journal-title":"Med Sci Monit"},{"key":"B90","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ensci.2016.04.007","article-title":"Hospital-based study on emergency admission of patients with Parkinson's disease","volume":"4","author":"Fujioka","year":"2016","journal-title":"eNeurologicalSci"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1276731","DOI":"10.3389\/fnagi.2023.1276731","article-title":"Complications and outcomes of hospitalizations for patients with and without Parkinson disease","volume":"15","author":"George","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"B92","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/mds.10648","article-title":"Parkinsonism in Ontario: comorbidity associated with hospitalization in a large cohort","volume":"19","author":"Guttman","year":"2004","journal-title":"Mov Disord"},{"key":"B93","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jocn.2016.03.005","article-title":"Epidemiology of inpatient stay in Parkinson's disease in the United States: Insights from the nationwide inpatient sample","volume":"31","author":"Mahajan","year":"2016","journal-title":"J Clin Neurosci."},{"key":"B94","doi-asserted-by":"publisher","first-page":"e0161271","DOI":"10.1371\/journal.pone.0161271","article-title":"Premotor symptoms as predictors of outcome in Parkinsons disease: a case-control study","volume":"11","author":"Wu","year":"2016","journal-title":"PLoS One"},{"key":"B95","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2147\/ndt.s3007","article-title":"Parkinson's disease and the frequent reasons for emergency admission","volume":"4","author":"Guneysel","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B96","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12890-016-0297-y","article-title":"Hospitalizations due to respiratory failure in patients with Amyotrophic Lateral Sclerosis and their impact on survival: a population-based cohort study","volume":"16","author":"Pisa","year":"2016","journal-title":"BMC Pulm Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s00115-017-0293-3","article-title":"Todesursachen bei amyotropher Lateralsklerose: Ergebnisse aus dem ALS-Register Rheinland-Pfalz [Causes of death in amyotrophic lateral sclerosis: Results from the Rhineland-Palatinate ALS registry]","volume":"88","author":"Wolf","year":"2017","journal-title":"Nervenarzt"},{"key":"B98","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.05.002","article-title":"Mortality and cost of pneumonia after stroke for different risk groups","volume":"21","author":"Wilson","year":"2012","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1410657","DOI":"10.3389\/fstro.2024.1410657","article-title":"Post stroke aspiration pneumonia, associated factors, and treatment outcome among stroke patients admitted to Tibebe Ghion Specialized Hospital, Bahir Dar, Ethiopia","volume":"3","author":"Nigus","year":"2024","journal-title":"Front Stroke"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.2147\/IJGM.S400420","article-title":"Incidence and predictors of aspiration pneumonia among stroke patients in Western Amhara Region, North-West Ethiopia: a retrospective follow up study","volume":"16","author":"Lidetu","year":"2023","journal-title":"Int J Gen Med"},{"key":"B101","doi-asserted-by":"publisher","first-page":"834240","DOI":"10.3389\/fneur.2022.834240","article-title":"The relationship between dysphagia and pneumonia in acute stroke patients: a systematic review and meta-analysis","volume":"13","author":"Chang","year":"2022","journal-title":"Front Neurol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1212\/WNL.0b013e31823152b1","article-title":"Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke","volume":"77","author":"Finlayson","year":"2011","journal-title":"Neurology"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1851936\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:45:15Z","timestamp":1784267115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1851936\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":102,"alternative-id":["10.3389\/fneur.2026.1851936"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1851936","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"article-number":"1851936"}}